These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. ClC-1 chloride channels: state-of-the-art research and future challenges. Imbrici P; Altamura C; Pessia M; Mantegazza R; Desaphy JF; Camerino DC Front Cell Neurosci; 2015; 9():156. PubMed ID: 25964741 [TBL] [Abstract][Full Text] [Related]
23. Neuromuscular excitability changes produced by sustained voluntary contraction and response to mexiletine in myotonia congenita. Ginanneschi F; Mignarri A; Lucchiari S; Ulzi G; Comi GP; Rossi A; Dotti MT Neurophysiol Clin; 2017 Jun; 47(3):247-252. PubMed ID: 28153715 [TBL] [Abstract][Full Text] [Related]
24. Low-rate repetitive nerve stimulation protocol in an Italian cohort of patients affected by recessive myotonia congenita. Modoni A; D'Amico A; Dallapiccola B; Mereu ML; Merlini L; Pagliarani S; Pisaneschi E; Silvestri G; Torrente I; Valente EM; Lo Monaco M J Clin Neurophysiol; 2011 Feb; 28(1):39-44. PubMed ID: 21221019 [TBL] [Abstract][Full Text] [Related]
25. Translational approach to address therapy in myotonia permanens due to a new SCN4A mutation. Desaphy JF; Carbonara R; D'Amico A; Modoni A; Roussel J; Imbrici P; Pagliarani S; Lucchiari S; Lo Monaco M; Conte Camerino D Neurology; 2016 May; 86(22):2100-8. PubMed ID: 27164696 [TBL] [Abstract][Full Text] [Related]
26. Clinical and electrophysiological reports in a case of early onset myotonia congenita (Thomsen's disease) successfully treated with mexiletine. Ceccarelli M; Rossi B; Siciliano G; Calevro L; Tarantino E Acta Paediatr; 1992 May; 81(5):453-5. PubMed ID: 1498517 [TBL] [Abstract][Full Text] [Related]
27. Paramyotonia congenita: abnormal short exercise test, and improvement after mexiletine therapy. Jackson CE; Barohn RJ; Ptacek LJ Muscle Nerve; 1994 Jul; 17(7):763-8. PubMed ID: 8008003 [TBL] [Abstract][Full Text] [Related]
28. Effect of mexiletine on transitory depression of compound motor action potential in recessive myotonia congenita. Lo Monaco M; D'Amico A; Luigetti M; Desaphy JF; Modoni A Clin Neurophysiol; 2015 Feb; 126(2):399-403. PubMed ID: 25065301 [TBL] [Abstract][Full Text] [Related]
29. Guidelines on clinical presentation and management of nondystrophic myotonias. Stunnenberg BC; LoRusso S; Arnold WD; Barohn RJ; Cannon SC; Fontaine B; Griggs RC; Hanna MG; Matthews E; Meola G; Sansone VA; Trivedi JR; van Engelen BGM; Vicart S; Statland JM Muscle Nerve; 2020 Oct; 62(4):430-444. PubMed ID: 32270509 [TBL] [Abstract][Full Text] [Related]
30. Blockers of Skeletal Muscle Na De Bellis M; Boccanegra B; Cerchiara AG; Imbrici P; De Luca A Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614292 [TBL] [Abstract][Full Text] [Related]
31. Flecainide-Responsive Myotonia Permanens With SNEL Onset: A New Case and Literature Review. Portaro S; Rodolico C; Sinicropi S; Musumeci O; Valenzise M; Toscano A Pediatrics; 2016 Apr; 137(4):. PubMed ID: 26944947 [TBL] [Abstract][Full Text] [Related]
32. Voltage-Gated Sodium Channel Blockers: Synthesis of Mexiletine Analogues and Homologues. Catalano A; Franchini C; Carocci A Curr Med Chem; 2021; 28(8):1535-1548. PubMed ID: 32364065 [TBL] [Abstract][Full Text] [Related]